Comparative Effectiveness of Lenalidomide/Dexamethasone-Based Triplet Regimens for Treatment of Relapsed and/or Refractory Multiple Myeloma in Subgroups Defined By Cytogenetic Risk
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:4308-4309 - Subject
- Language
- ISSN
- 0006-4971